Shenogen Pharma Group Ltd.

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . AbCellera Optimizing 500 Pot

Innovation is undoubtedly the key element in China’s healthcare investment scenario and early-stage venture capital funds continue to back home-grown new drug development with a total of 15 deals in t

BEIJING – Honey goat weed has long been used in China as a booster for male sexual function but an extract compound is now being developed by China’s Shenogen Pharma Group as a potential therapy f

China is establishing a formal legal framework for traditional Chinese medicines in a bid to grow market for the herbal remedies and other treatments common in the country for centuries into a robust